JCR Pharmaceuticals.
¥681
3
+¥2+0.29% Hari ini
Statistik
Harga Tertinggi Hari
694
Harga Terendah Hari
681
52M Tertinggi
1,339
52M Terendah
466
Volum
95,300
Volum Purata
464,783
Kapasiti Pasaran
269.79B
Nisbah P/E
18.88
Pendapatan Dividen
3.02%
Dividen
20.59
Akan Datang
23
OCT
Pendapatan
8
DEC
Bayaran Dividen
meningkat
31
MAR 25
Dividen Ex
menurun
30
SEP 25
Dividen Ex
Anggaran
8
DEC 25
Bayaran Dividen
Anggaran
31
MAR 26
Dividen Ex
Anggaran
30
SEP 26
Dividen Ex
Anggaran
Dividen
3.02%Pendapatan Dividen
Pertumbuhan 10T
14.01%
Pertumbuhan 5T
13.1%
Pertumbuhan 3T
-3.88%
Pertumbuhan 1T
-4.45%
Pendapatan
23OctDijangka
EPS yang dijangka
0.102508677896
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti 4552.TSE. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Mengenai
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Show more...
CEO
Mr. Shin Ashida
Pekerja
816
Negara
JP
ISIN
JP3701000006